1.PSEN1 p.Met233Val in a Complex Neurodegenerative Movement and Neuropsychiatric Disorder
Silke APPEL-CRESSWELL ; Ilaria GUELLA ; Anna LEHMAN ; Dean FOTI ; Matthew J FARRER
Journal of Movement Disorders 2018;11(1):45-48
Mutations in presenilin 1 (PSEN1) are the most common cause of autosomal dominant Alzheimer's disease. Here, we report a Canadian-Vietnamese family carrying a PSEN1 p.Met233Val mutation with an exceptionally early and severe presentation that includes a wide range of atypical symptoms, including prominent ataxia, Parkinsonism, spasticity, dystonia, action tremor, myoclonus, bulbar symptoms, seizures, hallucinations and behavioral changes. Whole-exome sequencing (WES) was performed on the affected proband after many assessments over several years proved diagnostically inconclusive. The results were analyzed using the AnnEx “Annotated Exomes” browser (http://annex.can.ubc.ca), a web-based platform that facilitates WES variant annotation and interpretation. High-throughput sequencing can be especially informative for complex neurological disorders, and WES warrants consideration as a first-line clinical test. Data analyses facilitated by web-based bioinformatics tools have great potential for novel insight, although confirmatory, diagnostically accredited Sanger sequencing is recommended prior to reporting.
Alzheimer Disease
;
Ataxia
;
Computational Biology
;
Dystonia
;
Exome
;
Hallucinations
;
Humans
;
Muscle Spasticity
;
Myoclonus
;
Nervous System Diseases
;
Parkinsonian Disorders
;
Presenilin-1
;
Seizures
;
Statistics as Topic
;
Tremor

Result Analysis
Print
Save
E-mail